NCT00410696View on ClinicalTrials.gov

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Hematological NeoplasmsTumors
Interventions
DRUG

Filgrastim

5 mcg/kg/day sc from day +1 after transplantation to hemopoietic reconstitution

DRUG

Pegfilgrastim

6 mg/day sc at day +1

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Armando Santoro, MD

OTHER

NCT00410696 - Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy | Biotech Hunter | Biotech Hunter